Skip to main content

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Estrategia de diagnóstico para la derivación de pacientes con infección activa por VHC desde atención primaria

IP: -
Collaborators: David Tabernero Caellas
Funding agency: Gilead Sciences, S.L.U.
Funding: 48599.7
Reference: GLD17/00276
Duration: 16/01/2018 - 15/01/2020

MUTACIONES DE RESISTENCIA A LOS NUEVOS TRATAMIENTOS VHC, CLAVE PARA OPTIMIZAR LA EFICIENCIA CLÍNICA Y PRESUPUESTARIA.

IP: -
Collaborators: Carolina Gonzalez Fernandez, Marta Bes Maijo, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 172727.5
Reference: PI15/00829
Duration: 01/01/2016 - 31/12/2018

Análisis de la interacción de los virus de la hepatitis B y D con el receptor del hepatocito y estudio prospectivo de la complejidad de sus quasiespecies virales

IP: Maria Buti Ferret
Collaborators: Lluís Viladomiu Catà, Maria del Mar Riveiro Barciela, Carolina Gonzalez Fernandez, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 147015
Reference: PI14/01416
Duration: 01/01/2015 - 31/12/2017

Malalties Hepatobiliars (GRC)

IP: -
Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties Hepatobiliars (GRC), Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Malalties Hepatobiliars (GRC), Damir Garcia Cehic, Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 421
Duration: 01/01/2014 - 31/12/2016

Related news

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Related professionals

Estela Garcia Gea

Estela Garcia Gea

Research technician
Psychiatry, Mental Health and Addictions
Read more
Erika Ivanna Araya

Erika Ivanna Araya

Postdoctoral researcher
Headache and Neurological Pain
Read more
Santiago Ramon y Cajal Agüeras

Santiago Ramon y Cajal Agüeras

Head of group
Translational Molecular Pathology
Read more
Lorena Viviana Lopez Reyes

Lorena Viviana Lopez Reyes

Research technician
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.